StockData
OPKO Health, Inc. logo

OPKO Health, Inc. (OPK) stock

OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)

Close on Nov 17, 2026Market cap $1.21BP/E –Yield –

OPKO Health price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

OPKO Health's price to sales ratio was 2.7× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 0.7× to 2.7×, with a median of 1.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.7×+1.0
2025Dec 31, 20251.7×+0.0
2024Dec 31, 20241.6×+0.3
2023Dec 29, 20231.3×+0.6
2022Dec 30, 20220.7×−1.0
2021Dec 31, 20211.7×−0.5
2020Dec 31, 20202.2×+1.2
2019Dec 31, 20191.0×−0.9
2018Dec 31, 20181.8×−0.7
2017Dec 29, 20172.6×−1.6
2016Dec 30, 20164.2×−15.2
2015Dec 31, 201519.3×−28.8
2014Dec 31, 201448.1×+18.4
2013Dec 31, 201329.8×−20.7
2012Apr 30, 201250.5×+4.0
2011Oct 31, 201146.5×−147.2
2010Dec 31, 2010193.7×–

More OPKO Health figures

See a number that looks wrong?